期刊文献+

rhG-CSF动员对供者血浆S1P浓度的影响 被引量:1

Impact of rhG-CSF on Sphingosine 1-phosphase Concentration in Blood Plasma of Donors
下载PDF
导出
摘要 1-磷酸鞘氨醇(S1P)是具有广泛生物学效应的磷脂代谢产物,多种生长因子均能通过影响细胞鞘氨醇激酶(SphK)活性而调节S1P的生成,重组人粒细胞集落刺激因子(rhG-CSF)是一种广泛用于外周血造血干细胞动员的一种细胞因子。本研究主要了解rhG-CSF动员对供者血浆S1P含量的影响。分离供者rhG-CSF动员前和动员第5天外周血单个核细胞和血浆,用RT-PCR检测动员前后单个核细胞SphKmRNA表达情况,并应用γ-32P-ATP掺入法和SphK酶促反应检测动员前后血浆S1P变化。结果表明,供者动员前后外周血单个核细胞均表达SphKmRNA;在rhG-CSF动员前后供者血浆中均含有S1P,且S1P浓度在rhG-CSF动员前和动员后第5天无明显变化(P>0·05)。结论rhG-CSF动员对供者血浆S1P含量无明显影响。 Sphingosine 1-phosphate (SIP), which can be impacted by different growth factors through sphingosine kinase (SphK) , is a bioactive lipid produced by metabolism of sphingolipid with various biological responses. Recombinant human granulocyte-colony-stimulating factor(rhG-CSF) have been used widely in peripheral blood stem/progenitor cell mobilization, This study was aimed to investigate the effects of rhG-CSF on SIP concentration in plasma of donors, The peripheral blood mononuclear cells and blood plasma were collected from 8 peripheral blood progenitor cell donors before mobilization and on the fifth day of mobilization with rhG-CSF. The SphK mRNA expression of blood mononuclear cells were detected by RT-PCR, The changes of SIP concentration were assayed with SphK enzyme catalyzed reaction, The results showed that both kinds blood mononuclear cells collected before and after rhG-CSF mobilization expressed SphK mRNA. The SIP concentration is low in donor's plasma both before and after mobilization with rhG-CSF, and there was no markedly change of Sl P concentration in plasma before and after mobilization( P 〉 0.05 ), In conclusion, mobilization with rhG-CSF does not impact SIP concentration in donors'plasma.
出处 《中国实验血液学杂志》 CAS CSCD 2006年第4期783-786,共4页 Journal of Experimental Hematology
基金 解放军总医院十五科研计划基金重点资助项目 编号01YZ05
关键词 重组人粒细胞集落刺激因子 外周血动员 血浆 1-鞘氨醇激酶 rhG-CSF peripheral blood Mobilization plasma sphingosine 1 -phosphate
  • 相关文献

参考文献8

二级参考文献62

  • 1Anderlini P, Rizzo J D, Nugent M L, et al. Peripheral blood stem cell donation: an analysis from the international bone marrow transplant registry (IBMTR) and european group for blood and marrow transplant (EB-MT) databases. Bone Marrow Transplantation, 2001,27: 689-- 692. 被引量:1
  • 2Brasel K, McKenna H J, Charrier K, et al. Flt3 ligand synergizes with granulocyte-macrophage colony-stimulating factor or granulocyte colony-stimulating factor to mobilize hematopoietic progenitor cells into the peripheral blood of mice.Blood,1997,90:3781-3788. 被引量:1
  • 3Anderlini P, Przepiorka D, Korbling M, et al. Blood stem cell procurement: donor safety issues. Bone Marrow Transplantation, 1998, 21(Suppl) :3S35--39. 被引量:1
  • 4Anderlini P, Korbling M. The use of mobilized peripheral blood stem cells from normal donors for allografting. Stem-Cells, 1997, 15: 9--17. 被引量:1
  • 5Anderlini P, Korbling M, Chan K W,et al. Long-term follow-up and safety of normal peripheral blood progenitor cell donors treated with filgrastim: the MD anderson cancer center experience [abstract]. Blood, 2001, 98:183--187. 被引量:1
  • 6Theilgaard M K, Raaschou J K, Andersen H, et al.Single leukapheresis products collected from healthy donors after the administration of granulocyte colony-stimulating factor contain ten-fold higher numbers of longterm reconstituting hematopoietic progenitor cells than conventional bone marrow allografts. Bone-MarrowTransnlant, 1999, 23: 243--249. 被引量:1
  • 7Hoef M V. HLA-identical sibling peripheral blood progenitor cell transplants (PBPCT). Bone Marrow Transplant, 1999. 24: 707--714. 被引量:1
  • 8Ottiger H D. Scheulen B. Beelen D W, et al. Immune reconstitution after allogeneic peripheral blood progenitor cell transplantation [abstract]. Bone marrow transplantation, 1996, 17 (Supp12):135--139. 被引量:1
  • 9Clark L, Clark O, Djulbegovic B, et al. Allogeneic peripheral blood stem cells vs bone marrow transplantation for the therapy of hematological malignancies: a meta-analysis of randomized controlled trials [abstract].Blood, 2001, 98:414--417. 被引量:1
  • 10Bensinger W I, Clift R, Martin P, et al. Allogeneic peripheral blood stem cell transplantation in patients with advanced malignancies:a retrospective comparison with marrow transplantation. Blood, 1996, 88:2794-- 2800. 被引量:1

共引文献20

同被引文献12

  • 1黄文荣,王立生,段海峰,高春记,鲁茁壮,王华,达万明.rhG-CSF对单核细胞鞘氨醇激酶活性影响的初步研究[J].中国实验血液学杂志,2007,15(1):156-159. 被引量:2
  • 2Goetzl EJ. Rosen H. Regulation of immunity by lysosphingolipids and their G protein-coupled receptors. J Clinl Ivest, 2004; 114 (11) : 1531 --11537. 被引量:1
  • 3Matloubian M, Lo CG, Cinamon G, et al. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature, 2004 ; 427 (6972) : 355 - 360. 被引量:1
  • 4Allende ML, Dreier JL, Mandala S, et al. Expression of the sphingosine 1-phosphate receptor, S1P1, on T-cells controls thymic emigration. J Biol Chem, 2004 ; 279 ( 15 ) : 15396 - 15401. 被引量:1
  • 5Dumont FJ. Fingolimod. Mitsubishi Pharma/Novartis. IDrugs, 2005 ; 8 (3) : 236 - 253. 被引量:1
  • 6Kim YM, Sachs T, Asavaroengchai W, et al. Graft-versus-host disease can be separated from graft-versus-lymphoma effects by control of lymphocyte trafficking with FTY720. J Clin Invest, 2003; 111(5) : 659 -669. 被引量:1
  • 7Clancy MJ, Marshall D, Dilworth M, et al. Immunosuppression is essential for successful allogeneic transplantation of the meta- nephros. Transplantation, 2009 ; 88(2) :151 - 159. 被引量:1
  • 8Tedesco-Silva H, Mourad G, Kahan BD, et al. FTY720, a novel immunomodulator: efficacy and safety results from the first phase 2A study in de novo renal transplantation. Transplantation, 2005; 79(11) : 1553 -1560. 被引量:1
  • 9Franzke A, Piao W, Lauber J, et al. G-CSF as immune regulator in T cells expressing the G-CSF receptor: implications for transplantation and autoimmune diseases. Blood, 2003 ; 102 ( 2 ) : 734 - 739. 被引量:1
  • 10Toh HC, Sun L, Soe Y, et al. G-CSF induces a potentially tolerant gene and immunophenotype profile in T cells in vivo. Clin Immunol, 2009 ; 132 ( 1 ) :83 - 92. 被引量:1

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部